Jessica Allen
Psychiatric/Mental Health · Maryville, TNNPI 1689123887
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,408 and has fallen 53.9% since, to $649 in 2025. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Neurocrine Biosciences, Inc.$773
- Otsuka America Pharmaceutical, Inc.$539
- AbbVie$536
- Lundbeck LLC$350
- Teva Pharmaceuticals USA, Inc.$342
- plus $1K from 12 others
What the payments were for
- Food & beverage$5,05599%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 55 | $1,210 |
| Neurocrine Biosciences, Inc. | 34 | $773 |
| Otsuka America Pharmaceutical, Inc. | 38 | $539 |
| AbbVie | 35 | $536 |
| Lundbeck LLC | 19 | $350 |
| Teva Pharmaceuticals USA, Inc. | 17 | $342 |
| Alkermes, Inc. | 17 | $322 |
| Vanda Pharmaceuticals Inc. | 12 | $308 |
| Axsome Therapeutics, Inc. | 10 | $290 |
| Sunovion Pharmaceuticals Inc. | 8 | $127 |
| Johnson & Johnson | 2 | $56 |
| Almatica Pharma LLC | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Neuronetics, Inc. | 2 | $42 |
| Tris Pharma Inc | 2 | $38 |
| Adlon Therapeutics L.p. | 2 | $36 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,102 in reported general payments places this provider in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 12 | $1,760 |
| Duloxetine Hcl | 16 | $347 |
| Clonazepam | 42 | $268 |
| Lamotrigine | 11 | $246 |
| Bupropion XlBupropion Hcl | 13 | $224 |
| Buspirone Hcl | 17 | $113 |
| Escitalopram Oxalate | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Maryville
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
- Mary AllenMemphis$422K
- Lauren HansenNashville$263K
- Joshua ThompsonChattanooga$262K
- Kristal HurstBlaine$260K
- Kaitlynn EarlsGreeneville$228K
- Tory WoodardCookeville$191K
- Sarah VogelfangerMemphis$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.